Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;13(3):519-520.
doi: 10.1111/1759-7714.14257. Epub 2022 Jan 2.

Optimal duration of adjuvant bisphosphonate treatment for high-risk early breast cancer: Results from a SUCCESS trial

Mingbei Lu  1 , Beibei Ren  1 , Lingyan Rao  1
Affiliations
Comment

Optimal duration of adjuvant bisphosphonate treatment for high-risk early breast cancer: Results from a SUCCESS trial

Mingbei Lu et al. Thorac Cancer. 2022 Feb.
No abstract available

Keywords: SUCCESS A trial; adjuvant bisphosphonate treatment; breast cancer; treatment duration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment on

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - PubMed
    1. Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):22. - PMC - PubMed
    1. Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun. 2020;40(5):205–10. - PMC - PubMed
    1. Clemons M, Gelmon KA, Pritchard KI, Paterson AH. Bone‐targeted agents and skeletal‐related events in breast cancer patients with bone metastases: the state of the art. Curr Oncol. 2012;19(5):259–68. - PMC - PubMed
    1. Liu H, Wang SH, Chen SC, Chen CY, Lin TM. Zoledronic acid blocks the interaction between breast cancer cells and regulatory T‐cells. BMC Cancer. 2019;19(1):176. - PMC - PubMed